Development of a biomarker of fibromyalgia on neuroinflammation.
- Conditions
- Fibromyalgia, chronic pain
- Registration Number
- JPRN-UMIN000048852
- Lead Sponsor
- Department of Psychosomatic Medicine, Graduate School of Medical Sciences, Kyushu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Not provided
[Fibromyalgia] (1) Patients with symptoms of anemia (hemoglobin 8 g/dl or less) (2) Patients with poor general condition (PS value >3) (3) Patients diagnosed with autoimmune disease, chronic infectious disease, demyelinating disease, complement-related disease (PNH, NMO, MS), malignant disease (4) Other patients deemed by the investigator to be inappropriate as research subjects. [Chronic pain] (1) Patients with symptoms of anemia (hemoglobin of 8 g/dl or less) (2) Patients with poor general condition (numerical value: PS value 3 or higher) (3) Those diagnosed with autoimmune disease, chronic infectious disease, demyelinating disease, complement-related disease (PNH, NMO, MS), or malignant disease (4) Other subjects deemed by the investigator to be inappropriate as research subjects. [Healthy control] (1) Those with symptoms of anemia (hemoglobin 8 g/dl or less) (2) Patients with poor general condition (PS value of 3 or higher) (3) Patients receiving treatment for pain (4) Those diagnosed with autoimmune disease, chronic infectious disease, demyelinating disease, complement-related disease (PNH, NMO, MS), or malignant disease (5) Any other person whom the investigator deems inappropriate as a research subject.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method